Purchase Order 75N93018P01325

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for DNA polymerase with a ceiling value of $35,250.56 on February 8, 2018, with ultimate completion on February 14, 2019. Place of performance is Carlsbad, California. The order is firm fixed price with no set-aside designation.</p>

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $11,502.40 purchase order to New England Biolabs, Inc. for biological supplies and reagent kits. The firm fixed price order is for the delivery of these products to Ipswich, Massachusetts between August 29 and October 15, 2023. As the prime contractor, New England Biolabs will supply the requested biological supplies and reagents to support the National...

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $10,508 purchase order to New England Biolabs, Inc., doing business as New England Biolabs, for reagent kits under catalog number 2186318. The firm fixed price order is for the delivery of these products to the prime contractor's facility in Ipswich, Massachusetts, with performance spanning from September 25, 2023 to December 1, 2023. No subcontractors or set...

This federal contract award is for the purchase of DNA Polymerase High Fidelity from Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The $19,832.00 firm fixed-price contract was awarded on October 29, 2014 by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The contract has an ultimate completion date of October 30, 2014 and does not utilize any set-aside designation. As a large manufacturer of...

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $19,888 purchase order to New England Biolabs, Inc. for NEW ENGLAND BIOLABS REAGENTS under contract number AMBIS #2182188. Performance will take place in Ipswich, Massachusetts over a four month period concluding on December 29, 2023. This firm fixed price contract has been set aside for total small businesses. As a leading life sciences company, New...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for Hot Star Plus DNA Polymerase (25,000 units) with a ceiling value of $12,237.36 on July 16, 2019. Place of performance is Bethesda, Maryland. Ultimate completion date is August 1, 2019. The order is firm fixed price with no set-aside applied.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Kapa Biosystems, Inc. valued at $36,395.40 on August 21, 2018. Place of performance is Andover, Massachusetts. The order is firm fixed price with no set-aside designation. Ultimate completion date is August 21, 2019. The originating opportunity was posted July 19, 2018 with a July 27, 2018 due date.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $17,478.36 on November 7, 2018, for HotStartAQ Plus DNA Polymerase (catalog number 203609, quantity 25,000 units) under firm fixed-price pricing. Work is performed in Valencia, California. The order is not set-aside and carries an ultimate completion date of November 25, 2018.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $5,947.89 on January 3, 2018, with ultimate completion on January 28, 2018. The order procures HOTSTARTAQ PLUS DNA Polymerase (5,000 units, catalog #203607) under firm fixed price terms. Place of performance is Valencia, California.</p>

The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a firm fixed price purchase order to New England Biolabs, Inc. (NEB) for the delivery of enzyme kits. The potential value of the contract is $100,464.00 and the completion date is September 25, 2020. NEB is a manufacturer and supplier of reagents, kits, and enzymes for the life sciences industry. Through prior federal contract awards and subcontractor roles, NEB has provided various...